Rythmol and Eye pain - a phase IV clinical study of FDA data

Summary:

Eye pain is reported as a side effect among people who take Rythmol (propafenone hydrochloride), especially for people who are female, 60+ old, also take Zofran, and have Chronic myeloid leukaemia.

The phase IV clinical study analyzes which people have Eye pain when taking Rythmol. It is created by eHealthMe based on reports of 3,422 people who have side effects when taking Rythmol from the FDA, and is updated regularly.

What is Rythmol?

Rythmol has active ingredients of propafenone hydrochloride. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 3,638 Rythmol users. Check the latest studies of Rythmol.

What is Eye pain?

Eye pain is found to be associated with 1,758 drugs and 2,465 conditions by eHealthMe. Check the latest studies of Eye pain.

On Jul, 13, 2026

3,422 people reported to have side effects when taking Rythmol.
Among them, 14 people (0.41%) have Eye pain.

Among these 14 people:

What is the gender of people who have Eye pain when taking Rythmol? *

female: 92.31 %
male: 7.69 %

What is the age of people who have Eye pain when taking Rythmol? *

What are other drugs people take besides Rythmol? *

What are other side effects people have besides Eye pain? *

Weakness: 8 people, 57.14%
Nausea (feeling of having an urge to vomit): 8 people, 57.14%
Weight Decreased: 7 people, 50.00%
Swallowing Difficulty: 7 people, 50.00%
Hair Loss: 7 people, 50.00%
Photophobia (extreme sensitivity to light): 7 people, 50.00%
Eye Irritation: 7 people, 50.00%
Dry Eyes (lack of adequate tears): 7 people, 50.00%
Drowsiness: 7 people, 50.00%
Stomatitis (inflammation of mucous membrane of mouth): 7 people, 50.00%

What are the existing conditions these people have? *

Ventricular Extrasystoles (premature cardiac contraction): 2 people, 14.29%
Hypotension (abnormally low blood pressure): 2 people, 14.29%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 14.29%
Vasculitis (inflammation of a blood vessel or blood vessels): 1 person, 7.14%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 7.14%
Nausea (feeling of having an urge to vomit): 1 person, 7.14%
High Blood Pressure: 1 person, 7.14%
Hepatitis C: 1 person, 7.14%
Genital Herpes (herpes infection of genital): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Rythmol and have Eye pain?

- Check whether Eye pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rythmol:

Rythmol (3,638 reports)

Eye pain treatments and more:

Eye pain (57,871 reports)

Browse all side effects of Rythmol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eye pain:

Eye pain (1,758 drugs)

Browse all the conditions that are associated with Eye pain:

Eye pain (2,465 conditions)

Related publications that referenced our studies

Tesic D, Kostic M, Paunovic D, Jankovic SM, "Analysis of the cost–effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia", Kardiologia Polska (Polish Heart Journal), 2016 Jan .
Tesic D, Kostic M, Paunovic D, Jankovic SM, "Analysis of the cost–effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia", Kardiologia Polska (Polish Heart Journal), 2016 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on propafenone hydrochloride (the active ingredients of Rythmol) and Rythmol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.